SCHEMBL1441833

SCHEMBL1441833

CC(C)NP(O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9275790 0.72
SCHEMBL6854760 0.72
SCHEMBL5954330 0.72
SCHEMBL3836561 0.67 TDP1 (0.36)
SCHEMBL3897780 0.65
SCHEMBL1551660 0.65
SCHEMBL2792564 0.65
SCHEMBL7122405 0.65
Bromide SCHEMBL3425347 0.64 TDP1 (0.33)
SCHEMBL1078973 0.64 TDP1 (0.67)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112585147-B MAP4K4 inhibitors 帝国理工学院创新有限公司 2023-12-05 CN disclosed
CN-112585147-A MAP4K4 inhibitors 帝国科技及医学学院 2021-03-30 CN disclosed
CN-108627647-B Detection and quantification method of post-translational modification proteomics 四川大学 2020-06-19 CN disclosed
WO-2011028218-A1 PROCESS FOR TRIPHOSPHATE OLIGONUCLEOTIDE SYNTHESIS ALNYLAM PHARMACEUTICALS, INC. (US) 2011-03-10 WO disclosed
EP-1409497-A2 METHOD FOR PREPARATION OF LNA PHOSPHORAMIDITES Santaris Pharma A/S (DK) 2004-04-21 EP disclosed
WO-2003006475-A2 METHOD FOR PREPARATION OF LNA PHOSPHORAMIDITES SANTARIS PHARMA A/S (DK) 2003-01-23 WO disclosed
WO-1995019373-A1 ANTIBODIES SPECIFIC FOR D-MYO-INOSITOL 1,4,5-TRISPHOSPHATE THE BOARD OF GOVERNORS FOR HIGHER EDUCATION, STATE OF RHODE ISLAND AND PROVIDENCE PLANTATIONS (US) 1995-07-20 WO disclosed
US-5393912-A D-myo-inositol 1,4,5-trisphosphate analogues THE BOARD OF GOVERNORS FOR HIGHER EDUCATION, STATE OF RHODE ISLAND AND PROVIDENCE PLANTATIONS (US) 1995-02-28 US disclosed
WO-1993005176-A1 IMPROVEMENTS IN OLIGONUCLEOTIDE PRIMERS AND PROBES MEDICAL RESEARCH COUNCIL (GB) 1993-03-18 WO disclosed